A clinical trial based on discoveries made by researchers in Columbia’s Pancreas Center is showing promising results and is now expanding to include more patients.
An expanding artificial heart valve being developed by Columbia surgeons and engineers could simplify treatment for many kids born with congenital heart disease.
A new study shows that omitting aspirin from an anti-clotting regimen can improve outcomes for people living with a heart pump by reducing hospitalizations without increasing the risk of blood clots.